The MIGHT Trial
The main purpose of this study/trial is to test whether patients with HMGCR myopathy can be safely and effectively treated with IVIG as their only medication for this condition. Participant Eligibility Potential subjects must meet the following: - Have a positive Anti-HMGCR antibody lab result within 12...

